Breakthrough technology offers promising treatment for ischemic retinopathy
Researchers develop technology that alleviates retinal pathologies by targeting mitochondrial chaperone TRAP1, which is implicated in the breakdown of blood-retinal barrier and pathological neovascularization. This treatment approach holds great promise for revolutionizing the treatment landscape for ischemic retinopathy.
SourceUlsan National Institute of Science and Technology(UNIST)·JournalAdvanced Science·DateJan 24, 2024